Td2 401(k) Plan
Sponsored by Translational Drug Development, Llc · EIN 464150915 · Plan #001
- Total assets
- $13.5M
- Net assets
- $13.5M
- Active participants
- 167
- With balances
- 221
Plan year beginning 01/01/2024 · 401(k)
Linked investment advisers
Advisory firms matched from Schedule C service providers (investment codes 26-28).
| Firm | Match | Plan year |
|---|---|---|
| Wells Fargo Advisors Financial Network, Llc CRD 11025 | fuzzy_auto · 94% | 2024 |
Service providers
Schedule C providers paid $5,000+ (large plans only).
| Provider | Services | Direct comp |
|---|---|---|
| Wells Fargo Advisors Financial Advi | Investment advisory (participants) | $30,424 |
| John Hancock Life Insurance Company | Recordkeeping, Investment management, Shareholder servicing fees | $2,289 |